Publications

BibTex format

@article{Awedew:2022:10.1016/s2666-7568(22)00213-6,
author = {Awedew, AF and Han, H and Abbasi, B and Abbasi-Kangevari, M and Ahmed, MB and Almidani, O and Amini, E and Arabloo, J and Argaw, AM and Athari, SS and Atlaw, D and Banach, M and Barrow, A and Bhagavathula, AS and Bhojaraja, VS and Bikbov, B and Bodicha, BBA and Butt, NS and Caetano, dos Santos FL and Dadras, O and Dai, X and Doan, LP and Eftekharzadeh, S and Fatehizadeh, A and Garg, T and Gebremeskel, TG and Getachew, ME and Ghamari, S-H and Gilani, SA and Golechha, M and Gupta, VB and Gupta, VK and Hay, SI and Hosseini, M-S and Hosseinzadeh, M and Humayun, A and Ilic, IM and Ilic, MD and Ismail, NE and Jakovljevic, M and Jayaram, S and Jazayeri, SB and Jema, AT and Kabir, A and Karaye, IM and Khader, YS and Khan, EA and Landires, I and Lee, S-W and Lee, SWH and Lim, SS and Lobo, SW and Majeed, A and Malekpour, M-R and Malih, N and Malik, AA and Mehrabi, Nasab E and Mestrovic, T and Michalek, IM and Mihrtie, GN and Mirza-Aghazadeh-Attari, M and Misganaw, AT and Mokdad, AH and Molokhia,},
doi = {10.1016/s2666-7568(22)00213-6},
journal = {The Lancet Healthy Longevity},
pages = {e754--e776},
title = {The global, regional, and national burden of benign prostatic hyperplasia in 204 countries and territories from 2000 to 2019: a systematic analysis for the Global Burden of Disease Study 2019},
url = {http://dx.doi.org/10.1016/s2666-7568(22)00213-6},
volume = {3},
year = {2022}
}

Download

RIS format (EndNote, RefMan)

TY  - JOUR
AB  - BackgroundBenign prostatic hyperplasia is a common urological disease affecting older men worldwide, but comprehensive data about the global, regional, and national burden of benign prostatic hyperplasia and its trends over time are scarce. As part of the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019, we estimated global trends in, and prevalence of, benign prostatic hyperplasia and disability-adjusted life-years (DALYs) due to benign prostatic hyperplasia, in 21 regions and 204 countries and territories from 2000 to 2019.MethodsThis study was conducted with GBD 2019 analytical and modelling strategies. Primary prevalence data came from claims from three countries and from hospital inpatient encounters from 45 locations. A Bayesian meta-regression modelling tool, DisMod-MR version 2.1, was used to estimate the age-specific, location-specific, and year-specific prevalence of benign prostatic hyperplasia. Age-standardised prevalence was calculated by the direct method using the GBD reference population. Years lived with disability (YLDs) due to benign prostatic hyperplasia were estimated by multiplying the disability weight by the symptomatic proportion of the prevalence of benign prostatic hyperplasia. Because we did not estimate years of life lost associated with benign prostatic hyperplasia, disability-adjusted life-years (DALYs) equalled YLDs. The final estimates were compared across Socio-demographic Index (SDI) quintiles. The 95% uncertainty intervals (UIs) were estimated as the 25th and 975th of 1000 ordered draws from a bootstrap distribution.FindingsGlobally, there were 94·0 million (95% UI 73·2 to 118) prevalent cases of benign prostatic hyperplasia in 2019, compared with 51·1 million (43·1 to 69·3) cases in 2000. The age-standardised prevalence of benign prostatic hyperplasia was 2480 (1940 to 3090) per 100 000 people. Although the global number of prevalent cases increased by 70·5% (
AU  - Awedew,AF
AU  - Han,H
AU  - Abbasi,B
AU  - Abbasi-Kangevari,M
AU  - Ahmed,MB
AU  - Almidani,O
AU  - Amini,E
AU  - Arabloo,J
AU  - Argaw,AM
AU  - Athari,SS
AU  - Atlaw,D
AU  - Banach,M
AU  - Barrow,A
AU  - Bhagavathula,AS
AU  - Bhojaraja,VS
AU  - Bikbov,B
AU  - Bodicha,BBA
AU  - Butt,NS
AU  - Caetano,dos Santos FL
AU  - Dadras,O
AU  - Dai,X
AU  - Doan,LP
AU  - Eftekharzadeh,S
AU  - Fatehizadeh,A
AU  - Garg,T
AU  - Gebremeskel,TG
AU  - Getachew,ME
AU  - Ghamari,S-H
AU  - Gilani,SA
AU  - Golechha,M
AU  - Gupta,VB
AU  - Gupta,VK
AU  - Hay,SI
AU  - Hosseini,M-S
AU  - Hosseinzadeh,M
AU  - Humayun,A
AU  - Ilic,IM
AU  - Ilic,MD
AU  - Ismail,NE
AU  - Jakovljevic,M
AU  - Jayaram,S
AU  - Jazayeri,SB
AU  - Jema,AT
AU  - Kabir,A
AU  - Karaye,IM
AU  - Khader,YS
AU  - Khan,EA
AU  - Landires,I
AU  - Lee,S-W
AU  - Lee,SWH
AU  - Lim,SS
AU  - Lobo,SW
AU  - Majeed,A
AU  - Malekpour,M-R
AU  - Malih,N
AU  - Malik,AA
AU  - Mehrabi,Nasab E
AU  - Mestrovic,T
AU  - Michalek,IM
AU  - Mihrtie,GN
AU  - Mirza-Aghazadeh-Attari,M
AU  - Misganaw,AT
AU  - Mokdad,AH
AU  - Molokhia,M
AU  - Murray,CJL
AU  - Narasimha,Swamy S
AU  - Nguyen,SH
AU  - Nowroozi,A
AU  - Nuñez-Samudio,V
AU  - Owolabi,MO
AU  - Pawar,S
AU  - Perico,N
AU  - Rawaf,DL
AU  - Rawaf,S
AU  - Rawassizadeh,R
AU  - Remuzzi,G
AU  - Sahebkar,A
AU  - Sampath,C
AU  - Shetty,JK
AU  - Sibhat,MM
AU  - Singh,JA
AU  - Tan,K-K
AU  - Temesgen,G
AU  - Tolani,MA
AU  - Tovani-Palone,MR
AU  - Valadan,Tahbaz S
AU  - Valizadeh,R
AU  - Vo,B
AU  - Vu,LG
AU  - Yang,L
AU  - Yazdanpanah,F
AU  - Yigit,A
AU  - Yiit,V
AU  - Yunusa,I
AU  - Zahir,M
AU  - Vos,T
AU  - Dirac,MA
DO  - 10.1016/s2666-7568(22)00213-6
EP  - 776
PY  - 2022///
SN  - 2666-7568
SP  - 754
TI  - The global, regional, and national burden of benign prostatic hyperplasia in 204 countries and territories from 2000 to 2019: a systematic analysis for the Global Burden of Disease Study 2019
T2  - The Lancet Healthy Longevity
UR  - http://dx.doi.org/10.1016/s2666-7568(22)00213-6
UR  - https://www.sciencedirect.com/science/article/pii/S2666756822002136?via%3Dihub
UR  - http://hdl.handle.net/10044/1/102202
VL  - 3
ER  -

Download

ProfessorSalmanRawaf

Contact

Assistant

Location

Summary

Citation

BibTex format

RIS format (EndNote, RefMan)